FDA-approved alkylating agents for the treatment of brain tumors
Medication | Tumor type | Mechanism of action | Reference |
---|---|---|---|
Temozolomide | GBM and anaplastic astrocytoma | Alkylating agent that leads to methylation and later apoptosis of impacted cells | [6] |
Carmustine | Glial tumors (wafers are frequently placed at the time of GBM resection as a bridge to radiation therapy) | Alkylating agent administered via intravenous injection or local implantation in wafer form | [7] |
Lomustine | Glial and non-glial cell tumors like medulloblastoma | Nitrosourea works as an alkylating agent | [8, 9] |